Fumaric Acid

Fumaric Acid

SCHEMBL9809229

COc1ccc(C=CCN2CCN(C(c3ccccc3)c3ccccc3)CC2)c(OC)c1.O=C(O)C=CC(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.50
HTR1A known ✓ P08908 1/20 0.50
ADRA2A known ✓ P08913 1/20 0.50
DRD2 known ✓ P14416 1/20 0.50
ADRA2B known ✓ P18089 1/20 0.50
ADRA2C known ✓ P18825 1/20 0.50
CHRM3 known ✓ P20309 1/20 0.50
DRD1 known ✓ P21728 1/20 0.50
SLC6A2 known ✓ P23975 1/20 0.50
ADRA1D known ✓ P25100 1/20 0.50
HTR2A known ✓ P28223 1/20 0.50
SLC6A4 known ✓ P31645 1/20 0.50
ADRA1A known ✓ P35348 1/20 0.50
HRH1 known ✓ P35367 1/20 0.50
HTR2B known ✓ P41595 1/20 0.50
SLC6A3 known ✓ Q01959 1/20 0.50
KCNH2 known ✓ Q12809 1/20 0.50
CACNA1C known ✓ Q13936 2/20 0.46
MEN1 known ✓ O00255 1/20 0.46
KMT2A known ✓ Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9809228 1.00 ALDH1A1 (0.52) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809227 1.00 ALDH1A1 (0.52) ALDH1A1THRBHPGDLMNAOPRD1
SCHEMBL1151665 0.93 LMNA (0.57) ALDH1A1THRBHPGDLMNAOPRD1
SCHEMBL1151668 0.93 LMNA (0.57) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809236 0.92 LMNA (0.51) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809232 0.92 LMNA (0.51) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809238 0.92 LMNA (0.51) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809239 0.85 ALDH1A1 (0.51) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809237 0.85 ALDH1A1 (0.51) ALDH1A1THRBHPGDLMNAOPRD1
Fumaric Acid SCHEMBL9809233 0.85 ALDH1A1 (0.51) ALDH1A1THRBHPGDLMNAOPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0187639-B1 NOVEL PIPERAZINE DERIVATIVES, PROCESSES FOR PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS AS ACTIVE INGREDIENT KANEBO, LTD. (JP) 1991-05-02 EP disclosed
US-4703048-A Novel 1-benzhydryl-4-cinnamylpiperazine derivatives, and pharmaceutical compositions comprising said compounds as active ingredient for treating a cerebrovascular disease KANEBO LTD. (JP) 1987-10-27 US disclosed
EP-0187639-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1986-07-16 EP disclosed